Regulatory & Legal
NMA: EMA press release on triggering re-evaluation of solutions for infusion containing hydroxyethyl-starch (HES)
NMA informs that EMA conclusioned from 2 studies that there is a low degree of compliance with restrictions designed to reduce the risk of kidney damage and death on HES usage.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you